Enzon Pharmaceuticals, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Myrexis, Inc. N/A -108K $0.39 -$41.93K
    SEC READ RANDOLPH C N/A +100K $0.15 +$15.07K
    SEC Bleznick Jordan N/A +100K $0.15 +$15.00K
    SEC Pearce Michael Cooper N/A -77K $0.19 -$14.65K
    SEC Pearce Michael Cooper N/A +506K $0.20 +$101.26K
    SEC Xstelos Corp. N/A +653K $0.14 +$91.38K
    SEC Xstelos Corp. N/A +51K $0.25 +$12.75K
    SEC Xstelos Corp. N/A +951K $0.24 +$228.15K
    SEC Xstelos Corp. N/A +998K $0.26 +$259.58K
    SEC ICAHN CARL C N/A +694K $0.41 +$284.55K
    SEC LEBUHN ROBERT N/A -56K $1.72 -$96.19K
    SEC LEBUHN ROBERT N/A -5.8K $6.58 -$38.30K
    SEC LEBUHN ROBERT N/A -1.9K $6.58 -$12.72K
    SEC HEBARD GEORGE Interim PEO and Interim COO +5K $6.88 +$34.40K
    SEC Conover Charles SVP, R&D Program Management -25K $6.78 -$169.50K
    SEC Rackear Andrew D. VP and General Counsel -1.6K $6.81 -$10.99K
    SEC Young Richard A N/A -2K $6.92 -$13.84K
    SEC Rackear Andrew D. VP and General Counsel -3.8K $6.68 -$25.16K
    SEC Buchbinder Aby VP, Clinical Development -2.7K $7.06 -$19.06K
    SEC LEBUHN ROBERT N/A -8.7K $10.57 -$91.98K
    SEC Ogden Mark L Acting VP of Fin & Prin FO +2K $10.65 +$21.30K
    SEC LEBUHN ROBERT N/A -10K $10.88 -$108.80K
    SEC HORAK IVAN D EVP, R&D, CSO -259K $10.67 -$2.76M
    SEC LEBUHN ROBERT N/A -10K $10.49 -$104.90K
    SEC TOOMAN CRAIG A Exec VP Finance, CFO -123K $11.25 -$1.38M
    SEC TOOMAN CRAIG A Exec. VP Finance, CFO -150K $9.27 -$1.39M
    SEC HORAK IVAN D EVP, R&D, CSO -101K $9.30 -$942.36K
    SEC Davit Paul Stephen Exec. Vice Pres. HR -2.8K $6.12 -$17.30K
    SEC HORAK IVAN D EVP, R&D, Chief Scientific Off -7K $6.12 -$43.05K
    SEC TOOMAN CRAIG A Exec VP Finance, CFO -5.9K $6.12 -$36.29K
    SEC TOOMAN CRAIG A Exec VP Finance, CFO -10K $6.33 -$65.24K
    SEC CLASSON ROLF A N/A +10K $4.06 +$40.60K
    SEC ANDO GORAN N/A +15K $3.77 +$56.55K
    SEC Renfro Phillip M N/A +10K $3.64 +$36.40K
    SEC BUCHALTER JEFFREY H Chairman, CEO & President +50K $3.28 +$164.00K
    SEC MICATI VICTOR P N/A +15K $3.28 +$49.20K
    SEC SALISBURY ROBERT C N/A +1.9K $3.22 +$6.25K
    SEC Renfro Phillip M N/A -15K $9.49 -$142.35K
    SEC Renfro Phillip M N/A -5.5K $9.46 -$51.91K
    SEC BUCHALTER JEFFREY H Chairman, CEO & President +5K $7.46 +$37.30K
    SEC Highbridge Convertible Arbitrage Master Fund, L.P. N/A +102K $6.50 +$665.23K
    SEC Highbridge Convertible Arbitrage Master Fund, L.P. N/A +60K $7.21 +$432.60K
    SEC Highbridge Convertible Arbitrage Master Fund, L.P. N/A +55K $7.71 +$424.05K
    SEC Highbridge Convertible Arbitrage Master Fund, L.P. N/A +22K $7.75 +$171.99K
    SEC Highbridge Convertible Arbitrage Master Fund, L.P. N/A +55K $7.73 +$421.39K
    SEC TOOMAN CRAIG A Exec VP Finance, CFO +1K $8.19 +$8.19K
    SEC Swieca Henry N/A +20K $8.25 +$167.09K
    SEC Swieca Henry N/A +45K $8.24 +$373.27K
    SEC Swieca Henry N/A +112K $8.24 +$919.19K
    SEC HIGHBRIDGE CAPITAL CORP N/A +69K $8.71 +$600.21K
    SEC CLASSON ROLF A N/A -30K $8.23 -$246.90K
    SEC BUCHALTER JEFFREY H Chairman, CEO & President +10K $6.86 +$68.60K
    SEC HORAK IVAN D EVP-R&D & Chief Scien. Officer +3K $6.87 +$20.61K
    SEC TOOMAN CRAIG A Exec VP Finance, CFO +1K $6.87 +$6.87K
    SEC Davit Paul Stephen Exec. Vice Pres. HR +6.5K $7.03 +$45.70K
    SEC HORAK IVAN D EVP-R&D & Chief Scien. Officer +5.5K $7.18 +$39.49K
    SEC BUCHALTER JEFFREY H Chief Executive Officer +10K $5.75 +$57.50K
    SEC GOLDE DAVID N/A -17K $14.37 -$248.89K

    Notifications